Here, to improve the anti-tumor effect of metformin and reduce lactic acidosis, we sought to investigate whether blocking the lactate/GPR81 pathway could enhance the anti-tumor effects of low concentrations of metformin. The gene discussed is HCAR1; the disease is neoplasm.